At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PROF Profound Medical Corp.
Market Closed 09-20 16:00:00 EDT
7.80
-0.04
-0.51%
盘后7.80
+0.000.00%
16:30 EDT
High8.02
Low7.67
Vol129.33K
Open7.71
D1 Closing7.84
Amplitude4.46%
Mkt Cap190.96M
Tradable Cap173.03M
Total Shares24.48M
T/O1.01M
T/O Rate0.58%
Tradable Shares22.18M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, palliative pain treatment of bone metastases, and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga, Canada.